APA citiranje

Abou‐Alfa, G. K., Blanc, J., Miles, S., Ganten, T., Trojan, J., Cebon, J., . . . Saltz, L. B. (2017). Phase II Study of First‐Line Trebananib Plus Sorafenib in Patients with Advanced Hepatocellular Carcinoma. Oncologist.

Citação norma Chicago

Abou‐Alfa, Ghassan K., et al. "Phase II Study of First‐Line Trebananib Plus Sorafenib in Patients With Advanced Hepatocellular Carcinoma." Oncologist 2017.

MLA citiranje

Abou‐Alfa, Ghassan K., et al. "Phase II Study of First‐Line Trebananib Plus Sorafenib in Patients With Advanced Hepatocellular Carcinoma." Oncologist 2017.